Suppr超能文献

继发于Thr60Ala转甲状腺素蛋白淀粉样变性的柔脑膜疾病:病例报告及文献复习

Leptomeningeal Disease Secondary to Thr60Ala Transthyretin Amyloidosis: Case Report and Review of the Literature.

作者信息

Carberry Nathan, Yu Sun, Fayerman Raisy N, Dugue Rachelle, Miller Michael, Tanji Kurenai, Goyal Tarini, Canoll Peter, Brannagan Thomas H

机构信息

Department of Neurology, Neuromuscular Division, University of Miami Miller School of Medicine, Miami, FL, USA.

Department of Pathology, Columbia University Irving Medical Center, New York, NY, USA.

出版信息

Neurohospitalist. 2023 Jan;13(1):90-95. doi: 10.1177/19418744221127849. Epub 2022 Oct 9.

Abstract

A 31-year-old woman with transthyretin (TTR) amyloidosis secondary to a Thr60Ala mutation developed recurrent stroke-like episodes with fluctuating mental status. Evaluation for stroke and seizures was unrevealing. She was found to have leptomeningeal contrast enhancement on magnetic resonance imaging, which was confirmed to be CNS TTR amyloidosis on histopathology following brain and dura biopsy. While leptomeningeal disease has rarely been known to be associated with TTR amyloidosis, this is the first documented case of leptomeningeal disease secondary to a Thr60Ala mutation in the TTR gene. A literature review of TTR amyloidosis is presented with special focus on the treatment of leptomeningeal TTR amyloidosis.

摘要

一名31岁患有继发于苏氨酸60丙氨酸(Thr60Ala)突变的转甲状腺素蛋白(TTR)淀粉样变性的女性出现反复的类似中风发作,伴有精神状态波动。对中风和癫痫的评估未发现异常。她在磁共振成像上显示软脑膜对比增强,经脑和硬脑膜活检后的组织病理学证实为中枢神经系统TTR淀粉样变性。虽然软脑膜疾病很少被认为与TTR淀粉样变性有关,但这是第一例记录在案的继发于TTR基因中Thr60Ala突变的软脑膜疾病病例。本文对TTR淀粉样变性进行了文献综述,特别关注软脑膜TTR淀粉样变性的治疗。

相似文献

1
Leptomeningeal Disease Secondary to Thr60Ala Transthyretin Amyloidosis: Case Report and Review of the Literature.
Neurohospitalist. 2023 Jan;13(1):90-95. doi: 10.1177/19418744221127849. Epub 2022 Oct 9.
2
A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis.
J Neurol Sci. 2008 Sep 15;272(1-2):186-90. doi: 10.1016/j.jns.2008.05.014. Epub 2008 Jun 24.
3
TTR associated leptomeningeal amyloidosis in a Sri Lankan patient.
J Neurol Sci. 2024 Nov 15;466:123273. doi: 10.1016/j.jns.2024.123273. Epub 2024 Oct 15.
4
Current Review of Leptomeningeal Amyloidosis Associated With Transthyretin Mutations.
Neurologist. 2021 Sep 7;26(5):189-195. doi: 10.1097/NRL.0000000000000337.
5
Early-Onset of Transthyretin Amyloidosis in a Young Afro-Caribbean Woman With Thr60Ala Mutation.
JACC Case Rep. 2020 Nov 4;2(13):2063-2067. doi: 10.1016/j.jaccas.2020.08.030. eCollection 2020 Nov.
6
Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation.
World Neurosurg. 2018 Mar;111:190-193. doi: 10.1016/j.wneu.2017.12.096. Epub 2017 Dec 23.
7
Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
Ophthalmology. 2007 Nov;114(11):e33-7. doi: 10.1016/j.ophtha.2007.07.007.
9
[Case of hereditary Y69H (p.Y89H) transthyretin variant leptomeningeal amyloidosis presenting with drop attacks and recurrent transient language disorder].
Rinsho Shinkeigaku. 2023 Oct 25;63(10):650-655. doi: 10.5692/clinicalneurol.cn-001852. Epub 2023 Sep 30.
10
Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.
J Neurol. 2015 Jan;262(1):228-34. doi: 10.1007/s00415-014-7594-2. Epub 2014 Dec 9.

引用本文的文献

2
Liver-directed drugs for transthyretin-mediated amyloidosis.
J Peripher Nerv Syst. 2022 Dec;27(4):228-237. doi: 10.1111/jns.12519. Epub 2022 Nov 16.

本文引用的文献

1
CNS Involvement in Hereditary Transthyretin Amyloidosis.
Neurology. 2021 Dec 14;97(24):1111-1119. doi: 10.1212/WNL.0000000000012965. Epub 2021 Oct 18.
2
Current Review of Leptomeningeal Amyloidosis Associated With Transthyretin Mutations.
Neurologist. 2021 Sep 7;26(5):189-195. doi: 10.1097/NRL.0000000000000337.
3
Early-Onset of Transthyretin Amyloidosis in a Young Afro-Caribbean Woman With Thr60Ala Mutation.
JACC Case Rep. 2020 Nov 4;2(13):2063-2067. doi: 10.1016/j.jaccas.2020.08.030. eCollection 2020 Nov.
4
Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis.
FEBS J. 2021 Jan;288(1):310-324. doi: 10.1111/febs.15339. Epub 2020 May 11.
5
Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.
Nat Rev Neurol. 2019 Jul;15(7):387-404. doi: 10.1038/s41582-019-0210-4. Epub 2019 Jun 17.
7
Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis.
Amyloid. 2019 Mar;26(1):10-14. doi: 10.1080/13506129.2018.1554563. Epub 2019 Jan 24.
8
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.
10
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.
N Engl J Med. 2018 Jul 5;379(1):22-31. doi: 10.1056/NEJMoa1716793.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验